The Effect of a Dietary Supplement Rich in Nitric Oxide in Patients Diagnosed With Primary Ciliary Dyskinesia.

Last updated: May 10, 2023
Sponsor: The University of Texas Health Science Center, Houston
Overall Status: Active - Recruiting

Phase

N/A

Condition

Dyskinesias

Treatment

Beet-it Juice

Clinical Study ID

NCT04489472
HSC-MS-19-0382
  • Ages 4-99
  • All Genders

Study Summary

The purpose of this study is to determine the effect of a dietary supplement rich in nitric oxide (NO) on nasal nitric oxide and fractional exhaled nitric oxide (FeNO),on ciliary beat frequency assessed by high-speed digital video microscopy and on lung function assessed by spirometry in normal patients and patients with Primary ciliary dyskinesia (PCD).

Eligibility Criteria

Inclusion

Inclusion Criteria:

Experimental group:

  • PCD patients

Control Group:

  • patients with no known chronic lung disease

  • 18 years to 99 years

Exclusion Criteria(both PCD patients and control group):

  • any other pulmonary co-morbidities and diseases entities like cystic fibrosis, nasal sinus surgery, nasal sinus hypoplasia/aplasia, deviated nasal septum, nasal polyps and with upper respiratory tract infection

  • patients allergic to beet

  • a known prolonged bleeding disorder.

Study Design

Total Participants: 20
Treatment Group(s): 1
Primary Treatment: Beet-it Juice
Phase:
Study Start date:
July 31, 2019
Estimated Completion Date:
May 01, 2024

Connect with a study center

  • The University of Texas Health Science Center at Houston

    Houston, Texas 77030
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.